Rasayani Biologics is a new drug development company, duly approved by the Department of Scientific and Industrial Research, (DSIR), Government of India. Rasayani Biologics works towards bridging the gap between Ayurvedic and modern pharmacology.

The R&D facility of Rasayani Biologics works to unearth the hidden potential of Ayurvedic drugs using nanotechnology and biotechnology. Ayurveda has immense potential for India and for international population. India’s contribution to the field of science and research has been insignificant. Contributions from Indian scientists who have migrated work in an entirely different atmosphere, however, scientists in India have shown little contribution. There have been many instances where Nobel laureates have deservedly won a prize for a concept that could well have been a part of Indian scientific understanding. But it was never scientifically proven to the world by the Indian scientific fraternity as required. Rasayani Biologics is on the path to create history in drug development.

Rasayani Biologics has drawn inspiration from Ayurvedic concepts and is on a mission to formulate pathbreaking drugs that can provide appropriate solutions to the medical challenges of the world. The medicines thus created will be used by doctors of all streams to fulfil the need of mankind. It need not be called an Ayurvedic drug anymore; it would be a medicine with universal acceptance.

The drug development follows standard norms as per the modern scientific demands, which consist of preclinical studies, in vitro studies, in vivo studies, human trials, safety trials, efficacy trials and seeking patents at the national and international levels.

The drugs currently under development following modern methodologies have already been used in clinics and verified through human trials. Their clinical studies and observation data has been compiled. Ayurvedic data compilation is patient-centric, based on patient responses, and employs an affordable methodology. It also follows the reverse pharmacology which incorporates transdisciplinary exploratory studies. Ayurveda has numerous drugs that can come within the domain of nanotechnology and biotechnology. Scientists at Rasayani Biologics (RBPL) work on these norms to find solutions to the current unmet need in medicine.